The board of directors of CLSA Premium Limited announced that Mr. Ma Xufei has tendered his resignation as the Company's independent non-executive Director, the chairman of the Company's remuneration committee and the member of each of the Company 's audit committee, corporate governance committee and nomination committee, due to other business engagements which require more of his dedication, with effect from 20 March 2024; and Mr. Ma Anyang (?Mr. Ma?) has been appointed as the Company's independent non- executive Director, the chairman of the Company's remuneration committee and the member of each of the Company's audit committee, corporate governance committee and nomination committee with effect from 21 March 2024. Mr. Ma, Justice of the Peace of New South Wales of Australia, aged 62, holds a Master's degree in herbal medicine and a Doctoral degree in medicine. He is an Australian registered Chinese herbal medicine practitioner and registered Chinese herbal dispenser.

Additionally, Mr. Ma currently serves as the president of the Chinese Medicine Industry Council of Australia Ltd. (CMIC). He is a standing member of the Australian mirror committee (HE031) of the Technical Committee 249 Traditional Chinese Medicine (ISO/TC 249) of the International Organization for Standardization. Furthermore, Mr. Ma is also a reference group member of the Chinese Medicine Board of Australia (CMBA) and an external advisory committee member of the traditional Chinese medicine program of Western Sydney University (WSU).

The Company has four Board committees, the membership of which is as follows: Audit Committee: Ms. Hu Zhaoxia as Chairman, Mr. Wu Jianfeng and Mr. Ma Anyang as Members. Nomination Committee: Mr. Li Jiong as Chairman, Ms. Hu Zhaoxia and Mr. Ma Anyang as Members. Remuneration Committee: Mr. Ma Anyang as Chairman, Mr. Yuan Feng Mr. Wu Jianfeng as Members.

Corporate Governance Committee: Mr. Xu Jianqiang as Chairman, Ms. Hu Zhaoxia Mr. Ma Anyang as Members.